Viral Vectors in Cancer Immunotherapy: International Review of Cell and Molecular Biology, cartea 379
Fernando Aranda Vega, Pedro Berraondo, Lorenzo Galluzzien Limba Engleză Hardback – 3 aug 2023
The use of genetically modified viruses allows the expression of pro-inflammatory molecules, while the immune system receives danger signals from the viruses themselves. In some cases, the virus can also induce tumor cell death. This book will review advances in virus-based cancer immunotherapy in both solid tumors and hematologic malignancies.
- Provides an overview of the landscape of virotherapy for solid tumors and hematologic malignancies
- Reviews advances in alphaviruses, adenoviruses, vaccinia viruses and Maraba virus
- Presents lessons on how to improve viruses to enhance immune responses
Preț: 955.53 lei
Preț vechi: 1332.08 lei
-28% Nou
Puncte Express: 1433
Preț estimativ în valută:
182.89€ • 190.10$ • 151.49£
182.89€ • 190.10$ • 151.49£
Carte tipărită la comandă
Livrare economică 29 ianuarie-12 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443192494
ISBN-10: 0443192499
Pagini: 274
Dimensiuni: 152 x 229 mm
Greutate: 0.54 kg
Editura: ELSEVIER SCIENCE
Seria International Review of Cell and Molecular Biology
ISBN-10: 0443192499
Pagini: 274
Dimensiuni: 152 x 229 mm
Greutate: 0.54 kg
Editura: ELSEVIER SCIENCE
Seria International Review of Cell and Molecular Biology
Public țintă
Professionals working in the area of oncology looking for up-to-date knowledge of newer immune-based therapies.Cuprins
1. Viral Vectors Engineered for Gene Therapy
Kenneth Lundstrom
2. Checkpoint blockade meets gene therapy: Opportunities to improve response and reduce toxicity
Noelia Silva-Pilipich, Ángela Covo-Vergara, Lucía Vanrell, and Cristian Smerdou
3. Armored modified vaccinia Ankara in cancer immunotherapy
Cigdem Atay, José Medina-Echeverz, Hubertus Hochrein, Mark Suter, and Maria Hinterberger
4. Alphaviruses in Cancer Immunotherapy
Kenneth Lundstrom
5. Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success
Irati Hervás-Corpión and Marta M. Alonso
6. Oncolytic viruses in hematological malignancies: hijacking disease biology and fostering new promises for immune and cell-based therapies
Mário Sousa-Pimenta, Ângelo Martins, and Vera Machado
7. Oncolytic virotherapy in lung cancer
Estanislao Nistal-Villan, Sergio Rius-Rocabert, and Francisco Llinares-Pinel
8. Rational selection of an ideal oncolytic virus to address current limitations in clinical translation
Rupsa Basu and Chad M. Moles
Kenneth Lundstrom
2. Checkpoint blockade meets gene therapy: Opportunities to improve response and reduce toxicity
Noelia Silva-Pilipich, Ángela Covo-Vergara, Lucía Vanrell, and Cristian Smerdou
3. Armored modified vaccinia Ankara in cancer immunotherapy
Cigdem Atay, José Medina-Echeverz, Hubertus Hochrein, Mark Suter, and Maria Hinterberger
4. Alphaviruses in Cancer Immunotherapy
Kenneth Lundstrom
5. Oncolytic viruses as treatment for adult and pediatric high-grade gliomas: On the way to clinical success
Irati Hervás-Corpión and Marta M. Alonso
6. Oncolytic viruses in hematological malignancies: hijacking disease biology and fostering new promises for immune and cell-based therapies
Mário Sousa-Pimenta, Ângelo Martins, and Vera Machado
7. Oncolytic virotherapy in lung cancer
Estanislao Nistal-Villan, Sergio Rius-Rocabert, and Francisco Llinares-Pinel
8. Rational selection of an ideal oncolytic virus to address current limitations in clinical translation
Rupsa Basu and Chad M. Moles